Herman Clinical Research, LLC

Suwanee, Georgia 30024

0 studies enrolling now · 13 studies all time

What they study most

Arthritis, Rheumatoid, Cardiovascular Disease, Chronic Disease, Chronic Inflammation, Chronic Kidney Disease, Chronic Pain, Colorectal Cancer, Diabetes Mellitus, Type 2, Dyslipidemias, High Cardiovascular Risk, Inflammaging, Obesity

Studies at this site

• A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting — Running, not enrolling
• A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight — Completed
• Informed Choice - Compass — Stopped early
• 2021 PMT iAge® Intervention Trial by Edifice Health — Stopped early
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial — Completed
• Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL — Paused
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Cardiovascular Inflammation Reduction Trial — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) — Stopped early
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Conversion to Embeda With Rescue Trial — Stopped early